Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04454203 · ClinicalTrials.gov registry record · Phase 4
Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension
A Phase 4 study of Intraoperative Hypertension and Total Ankle Arthroplasty, sponsored by Duke University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04454203: Recruiting Phase 4 study of Intraoperative Hypertension and Total Ankle Arthroplasty, sponsored by Duke University.
NCT04454203 is a Phase 4 study of Intraoperative Hypertension and Total Ankle Arthroplasty that is actively recruiting participants, run by Duke University. The registered enrollment target is 40 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04454203, a Phase 4 study of Intraoperative Hypertension and Total Ankle Arthroplasty, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this prospective randomized double-blind study is to determine if an ultrasound guided peri-arterial injection of local anesthetic (LA) superomedially the femoral artery via peripheral nerve catheter reverses ischemic hypertension associated with prolonged lower extremity tourniquet time.
Primary Outcome
Infiltrating study drug to reverse intraoperative tourniquet hypertension
Conditions Studied
Interventions
- DRUG Saline
- DRUG Mepivacaine
- PROCEDURE Perifemoral Injection of Local Anesthetic
Study Locations (1)
North Carolina
- Duke University Hospital - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-02-05 |
| Est. Completion | 2027-02-03 |
| Phase | Phase 4 |
What NCT04454203 shows while recruiting
NCT04454203 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 4 conditions, with Intraoperative Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Saline is the first listed.
NCT04454203 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04454203 about?
NCT04454203 is a clinical study titled "Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension". The goal of this prospective randomized double-blind study is to determine if an ultrasound guided peri-arterial injection of local anesthetic (LA) superomedially the femoral artery via peripheral nerve catheter reverses ischemic hypertension associated with prolonged lower extremity tourniquet time...
What is the current status of trial NCT04454203?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2021-02-05. Estimated completion is 2027-02-03.
What conditions does trial NCT04454203 study?
This clinical trial studies the following conditions: Intraoperative Hypertension, Total Ankle Arthroplasty, Ankle Fusion, Tourniquet Hypertension.
What interventions are being tested in trial NCT04454203?
The interventions under investigation include: Saline (DRUG), Mepivacaine (DRUG), Perifemoral Injection of Local Anesthetic (PROCEDURE).
Who is sponsoring clinical trial NCT04454203?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04454203 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraoperative Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04454203's enrollment target sits among peer trials
40 1397th of 2000 higher than 534 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI